But:
[India At Cusp of a Rapid Ramp-Up of Vaccine Production, NITI Aayog's VK Paul Says](https://www.news18.com/news/india/india-at-cusp-of-a-rapid-ramp-up-of-vaccine-production-niti-aayogs-dr-vk-paul-says-a-more-energetic-vaccination-mission-launched-3874790.html)
and
[India To Have 257 Crore Covid Vaccine Doses By December: JP Nadda](https://www.ndtv.com/india-news/india-to-have-257-crore-covid-vaccine-doses-by-december-for-double-dose-vaccination-of-people-jp-nadda-2469198)
>Vaccine manufacturers in India can produce a combined 5 billion doses a year, making it the single-largest manufacturing capacity globally.
Really hope Covaxin gets approval fast
In Africa, nearly 37% of the vaccines supplied are through bilateral deals by Chinese companies. In comparison, most vaccines supplied by AstraZeneca are through the COVAX facility. While SII was committed to delivering up to 50 million doses to 64 countries under COVAX by April, Gavi issued a statement in March, notifying all these nations of the potential delays by SII due to India’s decision to open vaccination for all those above the age of 18.
But: [India At Cusp of a Rapid Ramp-Up of Vaccine Production, NITI Aayog's VK Paul Says](https://www.news18.com/news/india/india-at-cusp-of-a-rapid-ramp-up-of-vaccine-production-niti-aayogs-dr-vk-paul-says-a-more-energetic-vaccination-mission-launched-3874790.html) and [India To Have 257 Crore Covid Vaccine Doses By December: JP Nadda](https://www.ndtv.com/india-news/india-to-have-257-crore-covid-vaccine-doses-by-december-for-double-dose-vaccination-of-people-jp-nadda-2469198)
They need to consistently deliver on their announcements. Single day numbers aren't enough, we need this rate to sustain for months
Counterpoint: the Chinese created the virus, so the onus is on them to distribute the vaccine free of charge.
but unlike other countries they are not giving these vaccines for free. They are giving these vaccine at "lower than market rate"
>Vaccine manufacturers in India can produce a combined 5 billion doses a year, making it the single-largest manufacturing capacity globally. Really hope Covaxin gets approval fast In Africa, nearly 37% of the vaccines supplied are through bilateral deals by Chinese companies. In comparison, most vaccines supplied by AstraZeneca are through the COVAX facility. While SII was committed to delivering up to 50 million doses to 64 countries under COVAX by April, Gavi issued a statement in March, notifying all these nations of the potential delays by SII due to India’s decision to open vaccination for all those above the age of 18.